NxStage Agrees to Merge with Fresenius, Horizon Pharma Lifts Outlook

Mukesh Buch
07 Aug, 2017
New York City

Booz Allen net soared 17%. First Data profit surged 22%. The GEO plunged despite 5% jump in revenues. Horizon Pharm lifted fiscal outlook. II-VI net more than doubled. Tyson Foods net declined 8% but revenues soared.

[R]12:00 PM New York – Booz Allen net soared 17%. First Data profit surged 22%. The GEO plunged despite 5% jump in revenues. Horizon Pharm lifted fiscal outlook. II-VI net more than doubled. Tyson Foods net declined 8% but revenues soared.[/R]

Tollbooth Index increased 30.77 or 0.3% to 12,411.56.

Earnings Review

Booz Allen Hamilton Holding Corporation ((BAH)) declined 5.4% or $1.86 to $32.76 after the engineering and consulting services provider reported revenues in the first-quarter ending in June advanced 5% from a year ago to $1.5 billion.

Net income in the quarter soared 17.3% to $79.5 million or 53 cents per diluted share from $67.8 million or 45 cents in the same quarter last year.

As of June 30, total backlog jumped 17% to $14.1 billion compared to $12 billion in a year ago period.

The engineering consultant forecasted fiscal 2017 revenues to grow in the range of 4% to 7% and diluted earnings per share between $1.80 and $1.90.

First Data Corp ((FDC)) slumped 2.5% or 47 cents to $18.11 after the payment technology provider stated total revenues in the second-quarter ending in June advanced 3% from a year ago to $3 billion.

Net income in the quarter surged 22% to $185 million or 20 cents per diluted share from $152 million or 17 cents in the same quarter last year.

The GEO Group Inc ((GEO)) plunged 6.1% or $1.70 to $26.36 after the real estate developer said revenues in the second-quarter ending in June advanced 4% from a year ago to $1.6 billion.

Net income in the quarter jumped 5.2% to $31 million or 25 cents per diluted share from $23.2 million or 21 cents in the same quarter last year.

GEO forecasted fiscal 2017 total revenues between $554 million and $559 million and diluted earnings per share in the range of 31 cents to 33 cents.

Horizon Pharma Plc ((HZNP)) jumped 4.9% or 62 cents to $13.32 after the biopharmaceutical products maker said net sales in the second-quarter ending in June soared 12% from a year ago to $289.5 million.

Net in the quarter swung to a loss of $209.5 million or $1.29 per diluted share from profit of $15 million or 9 cents in the same quarter last year.

Horizon lifted fiscal 2017 revenues forecast between $1.01 billion to $1.5 billion from earlier estimate of $985 million to $1.02 billion and operating profit in the range of $340 million to $375 million from $315 million and $350 million.

II-VI, Inc ((IIVI)) soared 8.1% or $2.85 to $38.20 after the optoelectronic components maker stated revenues in the fourth-quarter ending in June jumped 13% from a year ago to $273.7 million.

Net income in the quarter more than doubled to $32.6 million or 50 cents per diluted share from $14.3 million or 23 cents in the same quarter last year.

NxStage Medical, Inc ((NXTM)) surged 27.5 % or $6.35 to $29.50 after the home dialysis technology provider agreed to be acquired by Germany-based portable dialysis machinesprovider Fresenius SE & Co KGaA for $30 per share or about $2 billion in cash.

Tyson Foods, Inc ((TSN)) jumped 4.8% or $3.05 to $66.35 prepared foods provider reported total revenues in the second-quarter ending in June soared 5% from a year ago to $9.9 billion.

Net income in the quarter declined 7.6% to $447 million or $1.21 per diluted share from $484 million or $1.25 in the same quarter last year.

Zynerba Pharmaceuticals Inc ((ZYNE)) tumbled 54% or $8.13 to $6.93 after the cannabinoid treatments medicine maker said mid-stage clinical trial for cannabidiol gel in adult epilepsy didn''t meet its primary endpoint or secondary endpoints for either high or low dose cohorts compared to placebo.